IMMUNOLOGICAL AND BIOCHEMICAL-ALTERATIONS IN SEVERE FALCIPARUM-MALARIA - RELATION TO NEUROLOGICAL SYMPTOMS AND OUTCOME

被引:13
作者
DELORON, P
DUMONT, N
NYONGABO, T
AUBRY, P
ASTAGNEAU, P
NDARUGIRIRE, F
MENETRIERCAUX, C
BURDIN, N
BRELIVET, JC
PEYRON, F
机构
[1] INST MED & EPIDEMIOL AFRICAINES, PARIS, FRANCE
[2] KAMENGE UNIV HOSP, BUJUMBURA, BURUNDI
[3] UNIV LYON 1, PARASITOL LAB, F-69365 LYON, FRANCE
[4] SCHERING PLOUGH CORP, IMMUNOL RES LAB, DARDILLY, FRANCE
关键词
D O I
10.1093/clinids/19.3.480
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The relation between the immune response and the clinical features of severe falciparum malaria was studied in Burundian adults with (n = 31) and without (n = 17) cerebral involvement. At the time of admission, mean values for age, temperature, and blood levels of hemoglobin, creatinine, bilirubin, and glucose were similar in the two groups. Plasma levels of tumor necrosis factor alpha, interferon gamma, interleukin 10 (IL-10), and soluble intercellular adhesion molecule 1 were similarly elevated in the two groups. Mean parasite counts and mean plasma levels of soluble E-selectin were higher in severe noncerebral malaria than in cerebral malaria and were correlated with each other. After adjustment for parasitemia, levels of soluble E-selectin remained higher in noncerebral malaria. All seven patients who died had cerebral disease. These patients had higher levers of creatinine, bilirubin, IL-10, and soluble E-selectin than did patients with nonfatal cerebral malaria. After adjustment for creatinine and bilirubin levels, IL-10 and soluble E-selectin concentrations were similar in fatal and nonfatal cases of cerebral infection. In these African adults, none of the immunologic variables investigated was specific to cerebral malaria or to a fatal outcome.
引用
收藏
页码:480 / 485
页数:6
相关论文
共 27 条
[1]   STRATEGIES OF ANTICYTOKINE MONOCLONAL-ANTIBODY DEVELOPMENT - IMMUNOASSAY OF IL-10 AND IL-5 IN CLINICAL-SAMPLES [J].
ABRAMS, JS ;
RONCAROLO, MG ;
YSSEL, H ;
ANDERSSON, U ;
GLEICH, GJ ;
SILVER, JE .
IMMUNOLOGICAL REVIEWS, 1992, 127 :5-24
[2]   THE PATHOLOGY OF HUMAN CEREBRAL MALARIA [J].
AIKAWA, M ;
ISEKI, M ;
BARNWELL, JW ;
TAYLOR, D ;
OO, MM ;
HOWARD, RJ .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1990, 43 (02) :30-37
[3]   INTERCELLULAR-ADHESION MOLECULE-1 IS AN ENDOTHELIAL-CELL ADHESION RECEPTOR FOR PLASMODIUM-FALCIPARUM [J].
BERENDT, AR ;
SIMMONS, DL ;
TANSEY, J ;
NEWBOLD, CI ;
MARSH, K .
NATURE, 1989, 341 (6237) :57-59
[4]   SOLUBLE ICAM-1 LEVELS IN SERUM DURING ACUTE INFECTIOUS-MONONUCLEOSIS [J].
FURUKAWA, S ;
MOTOHASHI, T ;
MATSUBARA, T ;
IMAI, K ;
OKUMURA, K ;
YABUTA, K .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1993, 25 (02) :249-252
[5]  
GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792
[6]   CIRCULATING ADHESION MOLECULES IN DISEASE [J].
GEARING, AJH ;
NEWMAN, W .
IMMUNOLOGY TODAY, 1993, 14 (10) :506-512
[7]   TUMOR NECROSIS FACTOR AND DISEASE SEVERITY IN CHILDREN WITH FALCIPARUM-MALARIA [J].
GRAU, GE ;
TAYLOR, TE ;
MOLYNEUX, ME ;
WIRIMA, JJ ;
VASSALLI, P ;
HOMMEL, M ;
LAMBERT, PH .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (24) :1586-1591
[8]   MONOCLONAL-ANTIBODY AGAINST INTERFERON-GAMMA CAN PREVENT EXPERIMENTAL CEREBRAL MALARIA AND ITS ASSOCIATED OVERPRODUCTION OF TUMOR NECROSIS FACTOR [J].
GRAU, GE ;
HEREMANS, H ;
PIGUET, PF ;
POINTAIRE, P ;
LAMBERT, PH ;
BILLIAU, A ;
VASSALLI, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (14) :5572-5574
[9]   TUMOR-NECROSIS-FACTOR (CACHECTIN) AS AN ESSENTIAL MEDIATOR IN MURINE CEREBRAL MALARIA [J].
GRAU, GE ;
FAJARDO, LF ;
PIGUET, PF ;
ALLET, B ;
LAMBERT, PH ;
VASSALLI, P .
SCIENCE, 1987, 237 (4819) :1210-1212
[10]   PRODUCTION OF INTERFERON-GAMMA, INTERLEUKIN-2, INTERLEUKIN-4, AND INTERLEUKIN-10 BY CD4+ LYMPHOCYTES INVIVO DURING HEALING AND PROGRESSIVE MURINE LEISHMANIASIS [J].
HEINZEL, FP ;
SADICK, MD ;
MUTHA, SS ;
LOCKSLEY, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) :7011-7015